| # | Drug | Count |
|---|---|---|
| 0 | TREPROSTINIL | 564 |
| 1 | MACITENTAN | 372 |
| 2 | SILDENAFIL CITRATE | 361 |
| 3 | EPOPROSTENOL | 342 |
| 4 | TADALAFIL | 334 |
| 5 | AMBRISENTAN | 259 |
| 6 | SILDENAFIL | 237 |
| 7 | FOSCARBIDOPA/FOSLEVODOPA | 217 |
| 8 | ACETAMINOPHEN | 207 |
| 9 | FUROSEMIDE | 187 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | BACITRACIN AND POLYMYXIN B SULFATE | 1 | 0.0667 |
| 1 | BENZOCAINE AND BENZETHONIUM CHLORIDE | 1 | 0.0556 |
| 2 | APROCITENTAN | 1 | 0.0455 |
| 3 | BETAXOLOL HYDROCHLORIDE | 15 | 0.0288 |
| 4 | EPOPROSTENOL | 342 | 0.0261 |
| 5 | EPINEPHRINE HYDROCHLORIDE | 12 | 0.0253 |
| 6 | FOSCARBIDOPA/FOSLEVODOPA | 217 | 0.0246 |
| 7 | MOTIXAFORTIDE | 2 | 0.0196 |
| 8 | DEXTROMETHORPHAN HBR 20MG GUAIFENESIN 400MG | 1 | 0.0164 |
| 9 | DEXTROMETHORPHAN HBR AND GUAIFENESIN | 1 | 0.0133 |
| # | Drug class | Count |
|---|---|---|
| 0 | Prostacycline Vasodilator [EPC] | 861 |
| 1 | Endothelin Receptor Antagonist [EPC] | 610 |
| 2 | Phosphodiesterase 5 Inhibitor [EPC] | 456 |
| 3 | Nonsteroidal Anti-inflammatory Drug [EPC] | 280 |
| 4 | Loop Diuretic [EPC] | 229 |
| 5 | Osmotic Laxative [EPC] | 213 |
| 6 | Corticosteroid [EPC] | 207 |
| 7 | Factor Xa Inhibitor [EPC] | 150 |
| 8 | Proton Pump Inhibitor [EPC] | 133 |
| 9 | Benzodiazepine [EPC] | 128 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Hydrolytic Lysosomal Glycosaminoglycan-specific Enzyme [EPC] | 95 | 0.0071 |
| 1 | Prostacycline Vasodilator [EPC] | 861 | 0.0062 |
| 2 | Provitamin D2 Compound [EPC] | 117 | 0.0039 |
| 3 | Guanylate Cyclase-C Agonist [EPC] | 8 | 0.0039 |
| 4 | Soluble Guanylate Cyclase Stimulator [EPC] | 116 | 0.0034 |
| 5 | Phosphodiesterase 5 Inhibitor [EPC] | 456 | 0.0034 |
| 6 | Antisense Oligonucleotide [EPC] | 40 | 0.0033 |
| 7 | Human alpha-1 Proteinase Inhibitor [EPC] | 14 | 0.0033 |
| 8 | Endothelin Receptor Antagonist [EPC] | 610 | 0.0030 |
| 9 | Prostacyclin Receptor Agonist [EPC] | 75 | 0.0029 |